| Literature DB >> 35464784 |
Michael W Perry1, Lawrence R Kobulinsky2, Amy L Seybert2, Madeline S Kreider2, Victoria Williams2, Pamela L Smithburger2.
Abstract
Introduction: Faculty and staff from Duquesne University and the University of Pittsburgh Schools of Pharmacy created a simulation activity focused on the care of critically ill patients with coronavirus disease 2019 (COVID-19). Students on remote, short-term-care advanced pharmacy practice experiences (APPE) rotations from both universities worked in comingled teams and completed two educational electronic health record reviews, complex simulation sessions, and debriefs. Individually, students completed two educational electronic health record reviews and verbal patient presentations before and after the simulation sessions.Entities:
Keywords: COVID‐19; interactive learning; multiinstitutional systems; online learning; patient simulation; pharmacy education; remote education
Year: 2022 PMID: 35464784 PMCID: PMC9015639 DOI: 10.1002/jac5.1596
Source DB: PubMed Journal: J Am Coll Clin Pharm ISSN: 2574-9870
FIGURE 1Simulation definitions
FIGURE 2Schedule of individual student and group activities
Breakdown of student participation by cohort, school, and group
| Cohort | Total students | Total students by school | Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | Group 6 | Group 7 | Group 8 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1. May/June 2020 | 48 |
Pitt: 31 Duq: 17 |
4 2 |
4 2 |
4 2 |
4 2 |
4 2 |
4 2 |
4 2 |
3 3 |
| 2. July 2020 | 20 |
Pitt: 11 Duq: 9 |
4 3 |
4 3 |
3 3 | |||||
| 3. August 2020 | 24 |
Pitt: 6 Duq: 18 |
2 6 |
2 6 |
2 6 |
Note: Each cohort represents a different set of rotation students completing remote rotations.
Abbreviations: Duq = Duquesne University School of Pharmacy; Pitt = University of Pittsburgh School of Pharmacy.
ICE patient presentation results by assessment category
| Assessment category | N = 79 students | ||
|---|---|---|---|
| Baseline score: Median (range) | Final score: Median (range) |
| |
| Patient presentation total score (62 possible points) | 33 (28‐36) | 36.5 (29.5‐43.5) | .004 |
| Subjective score (15 possible points) | 7 (4‐10) | 6 (3‐9) | .087 |
| Objective score (7 possible points) | 3 (1‐5) | 5.5 (2‐7) | <.001 |
| Pharmaceutical plan (20 possible points) | 14.5 (12‐16.25) | 15.5 (13‐18) | <.001 |
| Monitoring (9 possible points) | 3 (3‐4) | 4 (3‐5) | <.001 |
| Communication (5 possible points) | 5 (5–5) | 5 (5‐5) | N/A |
Abbreviation: N/A = Not available.
Student self‐assessment survey results
| Assessment | Median (IQR) |
|
|---|---|---|
| Level of confidence in caring for an ARDS patient | ||
|
Baseline n = 76 Exit n = 96 |
4 (3‐6) 6 (5‐7) | <.001 |
| Level of confidence in managing sedation in a critically ill patient | ||
|
Baseline n = 77 Exit n = 96 |
6 (4‐7) 7 (5‐8) | .001 |
| Level of confidence in caring for a critically ill patient | ||
|
Baseline n = 76 Exit n = 96 |
3 (2‐4) 6 (5‐7.5) | <.001 |
| Level of confidence in caring for a short‐term ill patient with COVID‐19 | ||
|
Baseline n = 70 Exit n = 95 |
3 (2–4) 6 (4‐7) | <.001 |
| Level of understanding of challenges caring for a patient with COVID‐19 | ||
|
Baseline n = 77 Exit n = 96 |
4 (2‐5) 7 (5‐7.5) | <.001 |
| Level of understanding of the current therapeutic options for a patient with COVID‐19 | ||
|
Baseline n = 77 Exit n = 96 |
4 (2‐5) 7 (5–7.5) | <.001 |
| Level of understanding of the role of a pharmacist in regard to treating a patient with COVID‐19 | ||
|
Baseline n = 73 Exit n = 95 |
4 (3‐6) 7 (5‐8) | <.001 |
Note: Communication skills—reported separately in results.
Abbreviation: ARDS = Acute respiratory distress syndrome.
Scale of 1 to 10 (1 being not confident at all, 10 being completely confident).